Skip to main content
$1.23 -$0.02 (-1.6%)

04:00 PM EDT on 10/15/21

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $1.23 Mkt Cap $56.0M
Open $1.22 P/E Ratio 0.00
Prev. Close $1.23 Div. (Yield) $0.00 (0.0%)
Daily Range $1.20 - $1.26 Volume 1,049,200
52-Wk Range $1.14 - $7.02 Avg. Daily Vol. 1,251,026

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

147 Outperform
72 Underperform
 

All-Star Players

13 Outperform
19 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (67.20)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

NYSEMKT:PLX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: -91.17

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -223.97

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (67.20) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +299.98

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (< 20) Score: +735.37

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.24 2/10/2009 Underperform 3W $2.66 -53.01% +425.69% +478.70 0 Comment
anticitradeshort 27.85 4/20/2009 Underperform NS $2.27 -44.93% +426.42% +471.35 0 Comment
Spelunkin 26.09 11/3/2009 Underperform 5Y $10.39 -87.97% +329.59% +417.56 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -87.37% +327.98% +415.36 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -87.37% +327.98% +415.36 0 Comment
MSFOBV1YH 85.06 11/4/2009 Underperform 5Y $10.93 -88.56% +322.38% +410.95 0 Comment
ModernDayWarrior 21.65 10/29/2009 Underperform 5Y $9.58 -86.95% +323.67% +410.62 0 Comment
mathieugp 25.70 9/28/2009 Underperform 3M $7.87 -84.12% +325.04% +409.16 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -89.49% +319.40% +408.89 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -89.58% +312.84% +402.42 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.